This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Maeda, T. Articles by Friedl, A. Search for Related Content PubMed PubMed Citation Articles by Maeda, T. Articles by Friedl, A.

Induction of Syndecan-1 Expression in Stromal Fibroblasts Promotes Proliferation of Human Breast Cancer Cells

¹ Pathology and Laboratory Medicine Service, Department of Veterans Affairs Medical Center, Madison, Wisconsin;
² Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin; and
³ Department of Oncology, McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, Wisconsin

Infiltrating carcinomas characteristically elicit a reactive stromal response, and accumulating evidence indicates that tumor stroma fibroblasts reciprocally promote tumor development and growth. The cell surface heparan sulfate proteoglycan, syndecan-1 (Sdc1), is thought to function as a coreceptor for growth factor and extracellular matrix interactions, and Sdc1 expression is induced in reactive stromal cells in both mice and man. Mice with a targeted mutation in Sdc1 show reduced tumor development in response to oncogene expression and altered responses to other pathological stimuli that are associated with the induction of stromal Sdc1. Here, we test the hypothesis that Sdc1 is required for the growth-promoting activities of reactive stroma. We found that when highly invasive carcinoma cells (MDA-MB-231) were placed in contact with mouse embryonic fibroblasts (MEFs) in a coculture model, Sdc1 expression was induced. Sdc1 was not induced by less invasive or normal cell lines (T47D and NMuMG). Furthermore, the growth of MDA-MB-231 cells was enhanced by 42% when cocultured with Sdc1+/+ MEFs compared with Sdc1-/- MEFs. When T47D cells were cocultured with fibroblasts that expressed transfected Sdc1, these Sdc1-positive fibroblasts stimulated growth of the breast epithelial cells by 85% compared with untransfected controls. The growth-promoting effect was completely abolished when fibroblasts were transfected with mutant Sdc1 lacking heparan sulfate attachment sites. In conclusion, we have demonstrated that a growth-promoting loop exists between breast cancer cells and their stroma that depends on the activity of glycanated Sdc1.

This article has been cited by other articles:

				Y. B. Khotskaya, Y. Dai, J. P. Ritchie, V. MacLeod, Y. Yang, K. Zinn, and R. D. Sanderson Syndecan-1 Is Required for Robust Growth, Vascularization, and Metastasis of Myeloma Tumors in Vivo J. Biol. Chem., September 18, 2009; 284(38): 26085 - 26095. [Abstract] [Full Text] [PDF]

				G. Su, S. A. Blaine, D. Qiao, and A. Friedl Membrane Type 1 Matrix Metalloproteinase-Mediated Stromal Syndecan-1 Shedding Stimulates Breast Carcinoma Cell Proliferation Cancer Res., November 15, 2008; 68(22): 9558 - 9565. [Abstract] [Full Text] [PDF]

				Y. Chang, M. Zuka, P. Perez-Pinera, A. Astudillo, J. Mortimer, J. R. Berenson, and T. F. Deuel Secretion of pleiotrophin stimulates breast cancer progression through remodeling of the tumor microenvironment PNAS, June 26, 2007; 104(26): 10888 - 10893. [Abstract] [Full Text] [PDF]

				G. Su, S. A. Blaine, D. Qiao, and A. Friedl Shedding of Syndecan-1 by Stromal Fibroblasts Stimulates Human Breast Cancer Cell Proliferation via FGF2 Activation J. Biol. Chem., May 18, 2007; 282(20): 14906 - 14915. [Abstract] [Full Text] [PDF]

				S. Brule, N. Charnaux, A. Sutton, D. Ledoux, T. Chaigneau, L. Saffar, and L. Gattegno The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9 Glycobiology, June 1, 2006; 16(6): 488 - 501. [Abstract] [Full Text] [PDF]

				C. J. Fong, L. D. Burgoon, and T. R. Zacharewski Comparative Microarray Analysis of Basal Gene Expression in Mouse Hepa-1c1c7 Wild-Type and Mutant Cell Lines Toxicol. Sci., August 1, 2005; 86(2): 342 - 353. [Abstract] [Full Text] [PDF]

				T. Kelly, L. J. Suva, Y. Huang, V. MacLeod, H.-Q. Miao, R. C. Walker, and R. D. Sanderson Expression of Heparanase by Primary Breast Tumors Promotes Bone Resorption in the Absence of Detectable Bone Metastases Cancer Res., July 1, 2005; 65(13): 5778 - 5784. [Abstract] [Full Text] [PDF]

				Hasengaowa, J. Kodama, T. Kusumoto, Y. Shinyo, N. Seki, and Y. Hiramatsu Prognostic significance of syndecan-1 expression in human endometrial cancer Ann. Onc., July 1, 2005; 16(7): 1109 - 1115. [Abstract] [Full Text] [PDF]

				H. Kiaris, I. Chatzistamou, G. Trimis, M. Frangou-Plemmenou, A. Pafiti-Kondi, and A. Kalofoutis Evidence for Nonautonomous Effect of p53 Tumor Suppressor in Carcinogenesis Cancer Res., March 1, 2005; 65(5): 1627 - 1630. [Abstract] [Full Text] [PDF]